Johnson & Johnson, AstraZeneca to resume trial for Covid-19 vaccine
Earlier, AstraZeneca said it had been cleared by the FDA to restart a trial that had been halted in the U.S. after a volunteer participating in a U.K. trial of the shot had fallen ill
No comments:
Post a Comment